WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their TBPH stock forecasts and price targets.

Forecast return on equity

Is TBPH forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.9%

Forecast return on assets

Is TBPH forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TBPH revenue forecast

What is TBPH's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$67.7M+17.84%
Avg 2 year Forecast
$91.2M+58.82%
Avg 3 year Forecast
$142.0M+147.31%
TBPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TBPH revenue growth forecast

How is TBPH forecast to perform vs Biotechnology companies and vs the US market?
Company
33.77%
Industry
39.26%
Market
10.55%
TBPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TBPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TBPH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TBPH$8.93N/AN/A
MRNS$7.92$22.60+185.35%Buy
OCGN$1.69$7.00+314.20%Buy
NKTX$8.80$17.83+102.65%Strong Buy
CDMO$6.90$12.25+77.54%Strong Buy

Theravance Biopharma Stock Forecast FAQ

What is TBPH's revenue growth forecast for 2024-2026?

(NASDAQ: TBPH) Theravance Biopharma's forecast annual revenue growth rate of 33.77% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.26%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.55%.

Theravance Biopharma's revenue in 2024 is $57,424,000.On average, 3 Wall Street analysts forecast TBPH's revenue for 2024 to be $3,259,305,790, with the lowest TBPH revenue forecast at $3,077,724,841, and the highest TBPH revenue forecast at $3,448,111,446. On average, 3 Wall Street analysts forecast TBPH's revenue for 2025 to be $4,392,765,864, with the lowest TBPH revenue forecast at $4,123,380,652, and the highest TBPH revenue forecast at $4,647,894,322.

In 2026, TBPH is forecast to generate $6,840,014,677 in revenue, with the lowest revenue forecast at $5,876,094,376 and the highest revenue forecast at $8,026,166,941.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.

What is TBPH's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TBPH) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TBPH's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TBPH) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.